Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil
Authors:
Open Access
- 30 March 2022
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 193 (2) , 485-494
Abstract
Purpose: There is a paucity of data on the spectrum and prevalence of pathogenic variants among women of African ancestry in the Northeast region of Brazil. Methods: We performed BROCA panel sequencing to identify inherited loss-of-function variants in breast cancer susceptibility genes among 292 Brazilian women referred to a single institution cancer risk assessment program. Results: The study included a convenient cohort of 173 women with invasive breast cancer (cases) and 119 women who were cancer-free at the time of ascertainment. The majority of the women self-reported as African-descended (67% for cases and 90.8% for unaffected volunteers). Thirty-seven pathogenic variants were found in 36 (20.8%) patients. While the spectrum of pathogenic variants was heterogeneous, the majority (70.3%) of the pathogenic variants were detected in high-risk genes BRCA1, BRCA2, PALB2, and TP53. Pathogenic variants were also found in the ATM, BARD1, BRIP1, FAM175A, FANCM, NBN, and SLX4 genes in 6.4% of the affected women. Four recurrent pathogenic variants were detected in 11 patients of African ancestry. Only one unaffected woman had a pathogenic variant in the RAD51C gene. Different risk assessment models examined performed well in predicting risk of carrying germline loss-of-function variants in BRCA1 and/or BRCA2 in breast cancer cases. Conclusion: The high prevalence and heterogenous spectrum of pathogenic variants identified among self-reported African descendants in Northeast Brazil is consistent with studies in other African ancestry populations with a high burden of aggressive young onset breast cancer. It underscores the need to integrate comprehensive cancer risk assessment and genomic testing in the management of newly diagnosed Black women with breast cancer across the African Diaspora, enabling improved cancer control in admixed underserved and understudied populations.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Código de Financiamento – 001)
- American Cancer Society
- John and Editha Kapoor Charitable Foundation
- Susan G. Komen for the Cure (SAC110026)
- National Cancer Institute Specialized Programs of Research Excellence (P20CA233307)
- Secretaria de Saúde do Estado da Bahia
- Fundação de Apoio à Pesquisa e Extensão – FAPEX
- Paul Calabresi Career Development Award for Clinical Oncology (K12 CA139160)
This publication has 39 references indexed in Scilit:
- Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)BMC Cancer, 2013
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Cancer Epidemiology, Biomarkers & Prevention, 2012
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- Accurate and exact CNV identification from targeted high-throughput sequence dataBMC Genomics, 2011
- Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencingProceedings of the National Academy of Sciences, 2010
- Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous studyFamilial Cancer, 2010
- BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancerCancer, 2009
- Spectrum and characterisation of BRCA1 and BRCA2deleterious mutations in high-risk Czech patients with breast and/or ovarian cancerBMC Cancer, 2008
- Breast cancer risk associated with BRCA1 and BRCA2 in diverse populationsNature Reviews Cancer, 2007
- The R71GBRCA1is a founder Spanish mutation and leads to aberrant splicing of the transcriptHuman Mutation, 2001